Oncology

Microbiota long-term dynamics and prediction of acute graft-versus-host-disease in pediatric allogeneic stem cell transplantation
Anna Cäcilia Ingham, Katrine Kielsen, Hanne Mordhorst, Marianne Ifversen, Frank M. Aarestrup, Klaus Gottlob Müller, Sünje Johanna Pamp

medRxiv 2021.02.19.21252040; doi: https://doi.org/10.1101/2021.02.19.21252040

Add to Selected Citations
Path to drugging functional clones of luminal breast cancers using in-depth proteomics with spatially resolved mass spectrometry guided by MALDI imaging
N. Hajjaji, S. Aboulouard, T. Cardon, D. Bertin, YM. Robin, I. Fournier, M. Salzet

medRxiv 2021.02.16.21251694; doi: https://doi.org/10.1101/2021.02.16.21251694

Add to Selected Citations
Fat-enlarged Axillary Lymph Nodes are Associated with Node-Positive Breast Cancer in Obese Patients
Roberta M. diFlorio-Alexander, Qingyuan Song, Dennis Dwan, Judith A. Austin-Strohbehn, Kristen E. Muller, William B. Kinlaw, Todd A. MacKenzie, Margaret R. Karagas, Saeed Hassanpour

medRxiv 2021.02.17.20246504; doi: https://doi.org/10.1101/2021.02.17.20246504

Add to Selected Citations
Prostate cancer screening in hospitalized patients: Results from the Nationwide Inpatient Sample
Furqan B. Irfan, Fahad Shabbir Ahmed, Monica V. Masucci, Angelina A. Cerimele, Thu Nguyen, Aryana Sharrak, David M Nguyen, Tooba Tariq, Hussein Baydoun, Ahmad Hasan, Mohamed E Awad, Khaled Saleh, Patrick Karabon

medRxiv 2021.02.15.21251792; doi: https://doi.org/10.1101/2021.02.15.21251792

Add to Selected Citations
Patient and physician shared decision making behaviors in oncology: Evidence on adequate measurement properties of the iSHARE questionnaires
Hanna Bomhof-Roordink, Anne M. Stiggelbout, Fania R. Gärtner, Johanneke E.A. Portielje, Cor D. de Kroon, Koen C.M.J. Peeters, Karen J. Neelis, Jan Willem T. Dekker, Trudy van der Weijden, Arwen H. Pieterse, for the iSHARE study group

medRxiv 2021.02.12.21251610; doi: https://doi.org/10.1101/2021.02.12.21251610

Add to Selected Citations
RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancer
Joan W. Chen, Ryan P. Russell, Trushna Desai, Mary Fiel-Gan, Varun Bhat, Maria de Fátima Dias Gaui, Luis Claudio Amendola, Zilton Vasconcelos, Adam M. Brufsky, Marcia V. Fournier, Susan H. Tannenbaum

medRxiv 2021.02.10.21251517; doi: https://doi.org/10.1101/2021.02.10.21251517

Add to Selected Citations
Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with distinct homologous recombination deficiency associated DNA aberration profiles
Miklos Diossy, Viktoria Tisza, Hua Li, Jia Zhou, Zsofia Sztupinszki, Denise Young, Darryl Nousome, Claire Kuo, Yongmei Chen, Reinhard Ebner, Isabell A. Sesterhenn, Joel T. Moncur, Gregory T. Chesnut, Gyorgy Petrovics, Gregory T. Klus, Sandor Spisak, Gabor Valcz, Pier Vitale Nuzzo, Dezso Ribli, Aimilia Schina, Judit Börcsök, Aurel Prosz, Marcin Krzystanek, Thomas Ried, David Szuts, Salma Kaochar, Shailja Pathania, Alan D. D’Andrea, Istvan Csabai, Shiv Srivastava, Albert Dobi, Matthew L Freedman, Zoltan Szallasi

medRxiv 2021.02.08.21251199; doi: https://doi.org/10.1101/2021.02.08.21251199

Add to Selected Citations
epiLiver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)
David Cheishvili, Chifat Wong, Mohammad Mahbubul Karim, Mohammad Golam Kibria, Nusrat Jahan, Pappu Chandra Das, Md. Abul Khair Yousuf, Md. Atikul Islam, Dulal Chandra Das, Sheikh Mohammad Noor-E-Alam, Moshe Szyf, Wasif A. Khan, Mammun-Al-Mahtab

medRxiv 2021.02.07.21251315; doi: https://doi.org/10.1101/2021.02.07.21251315

Add to Selected Citations
Natural language processing for patient selection in phase I/II oncology clinical trials
Julie Delorme, Valentin Charvet, Muriel Wartelle, François Lion, Bruno Thuillier, Sandrine Mercier, Jean-Charles Soria, Mikael Azoulay, Benjamin Besse, Christophe Massard, Antoine Hollebecque, Loic Verlingue

medRxiv 2021.02.07.21249271; doi: https://doi.org/10.1101/2021.02.07.21249271

Add to Selected Citations
COVID-19 increases age- and sex-controlled 21-day fatality rates for patients with melanoma, hematologic malignancies, uterine cancer, or kidney cancer
Haiquan Li, Edwin Baldwin, Xiang Zhang, Colleen Kenost, Wenting Luo, Elizabeth A. Calhoun, Lingling An, Charles L. Bennett, Yves A. Lussier

medRxiv 2021.02.06.21251099; doi: https://doi.org/10.1101/2021.02.06.21251099

Add to Selected Citations

Oncology

Pages